Chapitre 30 · Produits pharmaceutiques
Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Vaccines for human medicine
3002.41.00
- Statut de la ligne
- Officiel
- Référence
- EAC CET 2022, Schedule 1
- Droit de douane
- 0 %
- Catégorie 0 · matières premières et biens d'équipement
- TVA
- Valeur en douane et droits perçus, hors TVA
- Droit d'accises
- 0
- Ne s'applique pas à cette ligne
- Unité statistique
- kg
- En vigueur depuis le 1 juillet 2022
Droits et taxes à l'importation
Tous les droits et taxes perçus à l'importation de cette marchandise, pour une origine hors CAE. Les montants forfaitaires dépendent du poids ou du nombre de conteneurs.
| Droit ou taxe | Taux | Base | Statut |
|---|---|---|---|
DD
Droit de douane (TEC CAE)
Indicatif
Exonéré si origine CAE
PrécisionsLe taux applicable dépend de la bande du TEC CAE à laquelle appartient la ligne tarifaire (0 %, 10 %, 25 % ou 35 %). Il n'y a pas de taux unique : voir le simulateur et le tarif détaillé par code SH. |
0 % | Valeur en douane | Indicatif |
VAT
Taxe sur la valeur ajoutée (nationale)
Indicatif
PrécisionsLa TVA est un impôt national, pas une taxe de la CAE : son taux varie selon l'État membre où l'importation est dédouanée (par exemple 16 % au Kenya, 18 % en Tanzanie, en Ouganda et au Rwanda, à la date de publication). Aucun taux unique n'est appliqué ici : vérifiez le taux en vigueur auprès de l'administration fiscale nationale compétente avant toute estimation. |
non chiffré | Valeur en douane et droits perçus, hors TVA | Indicatif |
Autres lignes de la position 3002
- 3002.12.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Antisera and other blood fractions 0 %
- 3002.13.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, unmixed, not put up in measured doses or in forms or packings for retail sale 0 %
- 3002.14.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, mixed, not put up in measured doses 0 %
- 3002.15.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes — Immunological products, put up in measured doses or in forms 0 %
- 3002.42.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Vaccines for veterinary medicine 0 %
- 3002.49.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products — Other 0 %
- 3002.51.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Cell cultures, whether or not modified — Cell therapy products 0 %
- 3002.59.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Cell cultures, whether or not modified — Other 0 %
- 3002.90.00 Human blood; animal blood prepared for therapeutic, prophy- lactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified — Other 0 %
Sources 2
-
01
EAC Common External Tariff, 2022 version (Schedules 1 and 2) (nouvel onglet), EAC Secretariat, institutional repository
Consulté le
-
02
East African Community, Customs Union (nouvel onglet), East African Community (eac.int)
Consulté le